Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Erie Retina Research is conducting and supporting more than 50–60 active clinical trials (phases ranging from early to late stage) in retinal diseases, notably age-related macular degeneration and diabetic retinopathy. They are renowned for rapid trial startup, high enrollment efficiency, and a perfect FDA audit success rate, leveraging both in-house and decentralized digital trial platforms. Dr. David Almeida, a leader in retinal research and surgery, leads the organization, which is known for both academic contributions and for supporting approval of pharmaceutical and device innovations in ophthalmology.[1][3][5][9]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Erie Retina Research.